Latest News in the pharma Industry
Research & Development
Alvotech and Yangtze River forge biosimilar deal for Chinese market
24 Nov 2020
The partnership will focus on commercializing eight biosimilar medicines in China for the domestic market
Read more
Early trial results hail Moderna's COVID-19 vaccine as 94.5% effective
17 Nov 2020
Data also show that mRNA-1273 remains stable at 2–8°, the temperature of a standard home or medical refrigerator, for 30 days.
Read more
European Commission wraps up CureVac COVID-19 vaccine supply deal
17 Nov 2020
Europeans set to benefit from the EC's authorization of COVID-19 candidate vaccine supply agreement, securing up to 405 million doses of CVnCoV
Read more
Vibalogics establishes US presence with virotherapy facility in Boston
16 Nov 2020
The specialist CDMO's $150 million 3-year investment plan will provide a complete suite of virotherapy services to support drug developers and their most "revolutionary" products.
Read more
Novasep to develop and manufacture Handl Therapeutics' gene therapy product
3 Nov 2020
The CDMO will supply drug substance and drug product to support Handl Therapeutics’ preclinical and clinical studies.
Read more
Pill Connect secures £0.5m to take electronic smart pill bottle to commercial launch
3 Nov 2020
Device provides clinicians and trialists with comprehensive data on a patient's adherence pattern.
Read more
Sanofi and GSK to support COVAX with 200 million doses of COVID-19 vaccine
28 Oct 2020
The companies anticipate first results of Phase I/II in early December 2020, to support the initiation of a pivotal Phase III study before the end of the year.
Read more
Russia submits Sputnik V emergency use and prequalification application to WHO
27 Oct 2020
The Russian Federation has become one of the first countries to apply to the WHO for prequalification of its vaccine, Sputnik V, against the novel coronavirus infection.
Read more
Shift towards precision medicines forcing innovation in oncology drug development
26 Oct 2020
Webinar addresses key challenges in oncology drug development as a result of the shift towards precision medicines and the increasing use of biomarkers
Read more
Vaccine manufacturing demand has had limited effect on regenerative medicine sector, panel tells CPhI audience
26 Oct 2020
The ramping up of vaccine manufacturing demand amid the COVID-19 pandemic had an initial impact on cell and gene therapy production but the regenerative medicine sector has largely weathered the storm, according to senior industry figures in a recent p...
Read more
Sai Life Sciences to boost biology capabilities at its integrated R&D campus
26 Oct 2020
The CRDMO will expand in vitro and in vivo biology services, DMPK and toxicology capabilities.
Read more
RedHill Biopharma secures expanded manufacturing for COVID-19 therapeutic candidate
20 Oct 2020
The biopharma company collaborates with European and Canadian suppliers for large-scale ramp-up of opaganib manufacturing.
Read more